Remodulin

Active Ingredient(s): Treprostinil
FDA Approved: * May 21, 2002
Pharm Company: * UNITED THERAP
Category: Blood Pressure

Treprostinil, sold under the brand names Remodulin for infusion, Orenitram for oral, and Tyvaso for inhalation, is a vasodilator that is used for the treatment of pulmonary arterial hypertension.[1] Treprostinil is a synthetic analog of prostacyclin (PGI2). Treprostinil was approved for use in the United States in May 2002.[2] The drug can be given in various forms: IV, subcutaneous injection, oral inhalation, as well as oral extended-release tablets. The subc... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Remodulin 20 mg/20ml Intravenous; Subcutaneous Injection, Solution
NDC: 66302-101
Labeler:
United Therapeutics Corporation
Remodulin 50 mg/20ml Intravenous; Subcutaneous Injection, Solution
NDC: 66302-102
Labeler:
United Therapeutics Corporation
Remodulin 100 mg/20ml Intravenous; Subcutaneous Injection, Solution
NDC: 66302-105
Labeler:
United Therapeutics Corporation
Remodulin 200 mg/20ml Intravenous; Subcutaneous Injection, Solution
NDC: 66302-110
Labeler:
United Therapeutics Corporation
Remodulin 2 mg/20ml Intravenous; Subcutaneous Injection, Solution
NDC: 66302-111
Labeler:
United Therapeutics Corporation
Remodulin 4 mg/20ml Intravenous; Subcutaneous Injection, Solution
NDC: 66302-112
Labeler:
United Therapeutics Corporation
Remodulin 8 mg/20ml Intravenous; Subcutaneous Injection, Solution
NDC: 66302-114
Labeler:
United Therapeutics Corporation
Remodulin 400 mg/20ml Intravenous; Subcutaneous Injection, Solution
NDC: 66302-120
Labeler:
United Therapeutics Corporation

Related Brands

Drugs with the same active ingredients